199 related articles for article (PubMed ID: 30954448)
1. C53: A novel particulate guanylyl cyclase B receptor activator that has sustained activity in vivo with anti-fibrotic actions in human cardiac and renal fibroblasts.
Chen Y; Zheng Y; Iyer SR; Harders GE; Pan S; Chen HH; Ichiki T; Burnett JC; Sangaralingham SJ
J Mol Cell Cardiol; 2019 May; 130():140-150. PubMed ID: 30954448
[TBL] [Abstract][Full Text] [Related]
2. Cenderitide: structural requirements for the creation of a novel dual particulate guanylyl cyclase receptor agonist with renal-enhancing in vivo and ex vivo actions.
Lee CY; Huntley BK; McCormick DJ; Ichiki T; Sangaralingham SJ; Lisy O; Burnett JC
Eur Heart J Cardiovasc Pharmacother; 2016 Apr; 2(2):98-105. PubMed ID: 27340557
[TBL] [Abstract][Full Text] [Related]
3. CRRL269: a novel designer and renal-enhancing pGC-A peptide activator.
Chen Y; Harty GJ; Huntley BK; Iyer SR; Heublein DM; Harders GE; Meems L; Pan S; Sangaralingham SJ; Ichiki T; Burnett JC
Am J Physiol Regul Integr Comp Physiol; 2018 Mar; 314(3):R407-R414. PubMed ID: 29187381
[TBL] [Abstract][Full Text] [Related]
4. Particulate Guanylyl Cyclase A/cGMP Signaling Pathway in the Kidney: Physiologic and Therapeutic Indications.
Chen Y; Burnett JC
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29584705
[TBL] [Abstract][Full Text] [Related]
5. Evidence for Angiotensin II as a Naturally Existing Suppressor for the Guanylyl Cyclase A Receptor and Cyclic GMP Generation.
Ma X; Iyer SR; Ma X; Reginauld SH; Chen Y; Pan S; Zheng Y; Moroni DG; Yu Y; Zhang L; Cannone V; Chen HH; Ferrario CM; Sangaralingham SJ; Burnett JC
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239899
[TBL] [Abstract][Full Text] [Related]
6. Discovery of another mechanism for the inhibition of particulate guanylyl cyclases by the natriuretic peptide clearance receptor.
Liu D; Ceddia RP; Zhang W; Shi F; Fang H; Collins S
Proc Natl Acad Sci U S A; 2023 Jul; 120(28):e2307882120. PubMed ID: 37399424
[TBL] [Abstract][Full Text] [Related]
7. Pro-Atrial Natriuretic Peptide: A Novel Guanylyl Cyclase-A Receptor Activator That Goes Beyond Atrial and B-Type Natriuretic Peptides.
Ichiki T; Huntley BK; Sangaralingham SJ; Burnett JC
JACC Heart Fail; 2015 Sep; 3(9):715-23. PubMed ID: 26362447
[TBL] [Abstract][Full Text] [Related]
8. Cardiac fibrosis in end-stage human heart failure and the cardiac natriuretic peptide guanylyl cyclase system: regulation and therapeutic implications.
Ichiki T; Schirger JA; Huntley BK; Brozovich FV; Maleszewski JJ; Sandberg SM; Sangaralingham SJ; Park SJ; Burnett JC
J Mol Cell Cardiol; 2014 Oct; 75():199-205. PubMed ID: 25117468
[TBL] [Abstract][Full Text] [Related]
9. Regulation of cGMP by soluble and particulate guanylyl cyclases in cultured human airway smooth muscle.
Hamad AM; Range S; Holland E; Knox AJ
Am J Physiol; 1997 Oct; 273(4):L807-13. PubMed ID: 9357856
[TBL] [Abstract][Full Text] [Related]
10. C-type natriuretic peptide as a podocyte hormone and modulation of its cGMP production by glucose and mechanical stress.
Lewko B; Endlich N; Kriz W; Stepinski J; Endlich K
Kidney Int; 2004 Sep; 66(3):1001-8. PubMed ID: 15327393
[TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidic acid inhibits C-type natriuretic peptide activation of guanylyl cyclase-B.
Abbey SE; Potter LR
Endocrinology; 2003 Jan; 144(1):240-6. PubMed ID: 12488350
[TBL] [Abstract][Full Text] [Related]
12. New aspects of Leydig cell function.
Middendorff R; Müller D; Paust HJ; Holstein AF; Davidoff MS
Adv Exp Med Biol; 1997; 424():125-38. PubMed ID: 9361777
[TBL] [Abstract][Full Text] [Related]
13. C-type natriuretic peptide regulation of guanosine-3',5'-cyclic monophosphate production in human endothelial cells.
Rautureau Y; Gowers I; Wheeler-Jones CP; Baxter GF
Auton Autacoid Pharmacol; 2010 Jul; 30(3):185-92. PubMed ID: 20085572
[TBL] [Abstract][Full Text] [Related]
14. Natriuretic peptide activation of extracellular regulated kinase 1/2 (ERK1/2) pathway by particulate guanylyl cyclases in GH3 somatolactotropes.
Jonas KC; Melrose T; Thompson IR; Baxter GF; Lipscomb VJ; Niessen SJ; Lawson C; McArdle CA; Roberson MS; McGonnell IM; Wheeler-Jones CP; Fowkes RC
Cell Tissue Res; 2017 Sep; 369(3):567-578. PubMed ID: 28451751
[TBL] [Abstract][Full Text] [Related]
15. BNP-induced activation of cGMP in human cardiac fibroblasts: interactions with fibronectin and natriuretic peptide receptors.
Huntley BK; Sandberg SM; Noser JA; Cataliotti A; Redfield MM; Matsuda Y; Burnett JC
J Cell Physiol; 2006 Dec; 209(3):943-9. PubMed ID: 16986166
[TBL] [Abstract][Full Text] [Related]
16. Neutral endopeptidase (CD10) is abundantly expressed in the epididymis and localized to a distinct population of epithelial cells--its relevance for CNP degradation.
Thong A; Müller D; Feuerstacke C; Mietens A; Stammler A; Middendorff R
Mol Cell Endocrinol; 2014 Jan; 382(1):234-243. PubMed ID: 24099862
[TBL] [Abstract][Full Text] [Related]
17. C-type natriuretic Peptide down-regulates expression of its cognate receptor in rat aortic smooth muscle cells.
Rahmutula D; Gardner DG
Endocrinology; 2005 Nov; 146(11):4968-74. PubMed ID: 16109786
[TBL] [Abstract][Full Text] [Related]
18. Presence and biological activity of C-type natriuretic peptide-dependent guanylate cyclase-coupled receptor in the penile corpus cavernosum.
Kim SZ; Kim SH; Park JK; Koh GY; Cho KW
J Urol; 1998 May; 159(5):1741-6. PubMed ID: 9554404
[TBL] [Abstract][Full Text] [Related]
19. Coexistence of C-type natriuretic peptide and atrial natriuretic peptide systems in the bovine cornea.
Kim SZ; Kim HS; Lee KS; Lee SJ; Seul KH; Koh GY; Cho KW; Kim SH
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2671-7. PubMed ID: 10937581
[TBL] [Abstract][Full Text] [Related]
20. Hyperammonemia inhibits the natriuretic peptide receptor 2 (NPR-2)-mediated cyclic GMP synthesis in the astrocytic compartment of rat cerebral cortex slices.
Zielińska M; Fresko I; Konopacka A; Felipo V; Albrecht J
Neurotoxicology; 2007 Nov; 28(6):1260-3. PubMed ID: 17629948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
